We are listing certain topics in which no RCTs have been done till now and which will answer some interesting questions
1. RCT in pseudocyst pancreas comparing laparoscopic cyst enterostomy with open procedures
We all have to go through journal orations. This site helps to get you the latest articles with our thoughts and comments
Sunitinib is a tyrosine kinase inhibitor and also inhibits VEGF and PGF improves survival in advanced pancreatic neuroendocrine tumors.
Feb 2011 NEJM
The trial had 171 patients with advanced disease, The patients were randomized to receive placebo or Sunitinib. The study was stopped early when the benefits of Sunitinib were realized.
Progression free survival of Sunitinib was 11.4 months and placebo 5 months
10% of the patients in Sunitinib group died and 25% in pacebo group. Hazard ratio 0.4%